New IVF injection aims to simplify fertility treatment
NCT ID NCT07350317
Summary
This study aims to see if a new, simpler progesterone injection (Prolutex) works as well as the current standard drug (cetrorelix) for controlling a key hormone during IVF. The goal is to prevent eggs from being released too early, which is crucial for a successful egg retrieval. About 230 women undergoing IVF will be randomly assigned to receive one of the two daily injections to directly compare their effectiveness.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASSISTED REPRODUCTIVE TECHNIQUES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.